POS1529 DOMAINS IMPACTING MINIMAL DISEASE ACTIVITY NON-ACHIEVEMENT IN PATIENTS WITH PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO TNFI RECEIVING GUSELKUMAB (COSMOS)

Abstract

BackgroundSustained minimal disease activity (MDA) is achieved by a minority of patients (pts) receiving biologics for psoriatic arthritis (PsA) [1]. Pt-reported MDA domains are less frequently achieved than physician-reported domains...